Horizon Pharma $800 million acquisition of Raptor Pharma

Overview:

• Horizon Pharma has acquired Raptor Pharma in an $800 million deal.
• The price tag comes to $9 per Raptor share.
• Raptor focuses on treatments for rare diseases.
• Horizon is domiciled in Ireland, and has its corporate offices in Illinois.
• Cooley (Barbara Borden, Kay Chandler, Sean Clayton, Mischi a Marca, Michael Tollini, Natasha Leskovsek) and McCann Fitzgerald advised Horizon. 
• Latham & Watkins (Charles Ruck, Kathleen Wells, Luke Bergstrom, John Manthei, Wesley Holmes) advised Raptor.
• Fried Frank Harris Shriver & Jacobson (Warren de Wied, Scott Luftglass) represented Raptor financial advisers Centerview Partners and Leerink Partners.

Kurt Stumpo - Journalist - North America and the Caribbean